The big news in Australia Stock Market is Creso Pharma to acquire Halucenex Life Sciences. Creso Pharma is engaged in the development of cannabis and hemp-derived therapeutic, nutraceutical, and lifestyle products. Earlier this week the Company announced the acquisition of psychedelics company, Halucenex Life Sciences. Here, Mr Bruce Linton, Creso Strategic Advisor, talks about the deal, the optimism surrounding it, and what could it mean for the Company. To know more about that watch this video.
Are You Looking for Compelling Stock Ideas from Diverse Sectors? Get Access to Kalkine's Investor/Resource Reports on a 7 days’ Free Trial.
GET A FREE STOCK REPORT
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.